ENZN Projected Dividend Yield

Enzon Pharmaceuticals Inc ( OTCBB : ENZN )

Enzon Pharmaceuticals is engaged in licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum. Vicineum, a drug being developed by Sesen, Inc., is approved for the treatment of non-muscle invasive bladder cancer.

22 YEAR PERFORMANCE RESULTS

ENZN Dividend History Detail
ENZN Dividend News
ENZN Competitors News
# of Shares: 0 Closing Price: 0.09 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2012 2.00 0% 0 $ 0.00 0.00%
2013 2.05 2% 0 $ 0.00 0.00%
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.85 0% 0 $ 0.00 0.00%
2016 0.15 0% 0 $ 0.00 0.00%
2017 0.15 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.12 0% 0 $ 0.00 126.98%
2025 0.00 0% 0 $ 0.00 126.98%
2026 0.00 0% 0 $ 0.00 126.98%
2027 0.00 0% 0 $ 0.00 126.98%
2028 0.00 0% 0 $ 0.00 126.98%
2029 0.00 0% 0 $ 0.00 126.98%
2030 0.00 0% 0 $ 0.00 126.98%
2031 0.00 0% 0 $ 0.00 126.98%
2032 0.00 0% 0 $ 0.00 126.98%
2033 0.00 0% 0 $ 0.00 126.98%
2034 0.00 0% 0 $ 0.00 126.98%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 126.98%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2019
Aug 22, 2019
Sep 30, 2019
Oct 01, 2019
Oct 15, 2019
0.1200
2019
Jan 30, 2019
Feb 20, 2019
Feb 21, 2019
Mar 21, 2019
0.0600
2019 Total:
0.1800
X
Search Dividend Investor